Axa S.A. Charles River Laboratories International, Inc. Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $4.55 Million - $5.59 Million	-12,200 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $647,174 - $817,630	-2,200 Reduced 15.28%	12,200 $4.51 Million
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $3.1 Million - $3.71 Million	12,400 Added 620.0%	14,400 $4.17 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $155,400 - $176,834	700 Added 53.85%	2,000 $500,000
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $154,492 - $246,636	1,300 New	1,300 $227,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.